[196 Pages Report] The infant formula ingredients market is estimated to be valued at USD 16.7 billion in 2019 and is projected to grow at a CAGR of 7.3% from 2019, to reach a value of USD 25.5 billion by 2025. Rise in the number of women joining workforce post giving birth, the inability of mothers to lactate, and parents seeking additional sources of nutrition for their babies are among the key factors expected to boost sales of infant formula ingredients in the years to come. Apart from this, infant formula ingredients manufacturers have invested in R&D, which is further expected to drive the growth of the infant formula ingredients industry in the years to come.
By source, the cow milk segment is projected to dominate the market during the forecast period.
Cow milk-based ingredients find widescale usage across Europe and North America regions owing to its acceptance as a cost-effective manufacturing process, and cow milk-based ingredients are available in bulk. Apart from this, most of the infant formula manufacturers use cow-based ingredients, including Nestlé S.A. (Switzerland), Abbott Laboratories (US), and Mead Johnson & Company, LLC (US).
By form, the powder segment is projected to dominate the market during the forecast period.
Infant formula ingredients are commonly used in the powdered form, owing to its ease of handling compared to liquid infant formula ingredients. Several types of infant formula ingredients such as carbohydrates, proteins, some fats, and prebiotics are commonly used in powdered form by infant formula manufacturers. Thus, high growth prospects lie ahead for powder infant formula manufacturers in the coming years, especially from the emerging countries.
Extensive R & D by companies operating in the infant formula market
Manufacturers involved in the infant formula ingredients market are consistently engaged in R&D to develop ingredients as per consumer’s expectations. In 2019, Nestlé (Switzerland), opened a new R&D center in Ireland. The company made an investment of USD 30.0 million for the same. The center will focus on developing products for infant nutrition. Arla Foods amba (Denmark), made an investment of USD 0.66 million for a project focusing on infant formula. The project investigated whether a diet with bioactive milk ingredients protects against gut inflammation which is of enormous relevance to improve infant formula. BASF (Germany) and GlycoSyn (US) formed a partnership with a focus on the area of infant nutrition. It involved the development and commercialization of human milk oligosaccharides (HMOs). In 2019, BASF launched its first HMO, PREBILAC 2’-FL for the infant nutrition market. Thus, the market is highly competitive, with a large number of key players involved. Most of these players are expanding their base in the market owing to its increased demand from various countries.
Key Market Players
The key players in global infant formula ingredients market include AAK AB (Sweden), Fonterra Co-operative Group Limited (New Zealand), Carbery Food Ingredients Limited (Ireland), Royal Friesland Campina N.V. (Netherlands), Sachsenmilch Leppersdorf GmbH (Germany), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), Arla Foods amba (Denmark), Chr. Hansen Holdings A/S (Denmark), Kerry Group plc (Ireland), Lactalis Ingredients (France), Glanbia plc (Ireland), and Vitablend Nederland B.V. (Netherlands).
Scope of the report
|Market size available for years||2017-2025|
|Base year considered||2018|
|Forecast units||Value (USD Million) and Volume (KT)|
|Segments covered||Ingredient Type, Source, Form, and Application|
|Geographies covered||North America, Europe, Asia Pacific, and Rest of World (RoW)|
|Companies covered||AAK AB (Sweden), Fonterra Co-operative Group Limited (New Zealand), Carbery Food Ingredients Limited (Ireland), Royal Friesland Campina N.V. (Netherlands), Sachsenmilch Leppersdorf GmbH (Germany), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), Arla Foods amba (Denmark), Chr. Hansen Holdings A/S (Denmark), Kerry Group plc (Ireland), Lactalis Ingredients (France), Glanbia plc (Ireland), and Vitablend Nederland B.V. (Netherlands)|
This research report categorizes the market based on ingredient type, source, form, application, and region.
Based on Type, the market has been segmented as follows:
- Fats & Oils
- Others (Probiotics, Nucleotides, and Emulsifiers)
Based on the Source, the market has been segmented as follows
- Cow Milk
- Protein hydrolysates
- Others (Goat milk and camel milk)
Read more- https://www.prnewswire.com/news-releases/infant-formula-ingredients-market-worth-25-5-billion-by-2025–exclusive-report-by-marketsandmarkets-300923990.html